XPOF · Xponential Fitness, Inc.

The thesis

Xponential Fitness shares are priced on the hope of a sale while the business shrinks, and that mix makes them more likely to lag the S&P 500 than lead it over the next three months. Two events settle it: the third-quarter report, expected around 5 November 2026, and any result from the board's strategic review.

The company is a boutique fitness franchisor with five brands: Club Pilates, Pure Barre, YogaSix, BFT and StretchLab. On 6 April 2026 its board started a review of strategic alternatives, including a sale or merger, with Jefferies as adviser. That followed public pressure in March from Voss Capital, which then controlled 19.3% of the shares. Six months later no deal has been announced. Over the same period the company's August results showed same-store sales falling and full-year guidance cut.

The narrative is maturing: the sale story has been public since 6 April 2026, and UBS cut its target to $4.50 on 16 September 2026 with no transaction news in between. The shares closed at $4.95 on 9 October 2026, above the UBS target.

Bullish and bearish views on Xponential Fitness, Inc.

The bull case on Xponential Fitness, Inc. (XPOF), in brief: A sale process is formally under way. The bear case: Studio sales are falling.

Bull case

• A sale process is formally under way. The board hired Jefferies on 6 April 2026 to evaluate a sale, merger or other transaction, after three directors resigned and the board shrank to five members. Voss Capital's 19.3% stake, disclosed in its March 2026 letter, gives a large holder a direct push toward a deal.
• New CFO has deal experience. An 8-K dated 1 September 2026 named Jennifer Ryu chief financial officer, effective 19 October 2026. She has been CFO of Resources Connection since 2019 and brings more than 25 years in finance and mergers and acquisitions. She replaces an interim CFO who had served since March 2026.
• Franchise demand still exists. In the second quarter of 2026 the company opened 67 gross new studios and sold 53 franchise licenses, according to its 6 August 2026 release. North American system-wide sales held flat year on year at $437.3 million.

Bear case

• Studio sales are falling. Same-store sales fell 6.8% in the second quarter of 2026, against 2.4% growth a year earlier. Quarterly average unit volume (sales per studio) dropped to $659,000 from $686,000, according to the 6 August 2026 release.
• Guidance was cut in August. On 6 August 2026 the company lowered its 2026 forecast to revenue of $250.0–$260.0 million, adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of $91.0–$97.0 million, and about 150 net new studio openings. Second-quarter revenue fell 13% to $66.0 million, and the company swung to a $4.8 million net loss.
• Heavy debt against thin cash. At 30 June 2026 the company held $25.0 million in cash against $522.4 million of long-term debt. That debt load limits what a buyer would pay for the equity and leaves little room if same-store sales keep falling.
• Analysts are not supportive. UBS kept a Neutral rating and cut its target to $4.50 on 16 September 2026, below the 9 October 2026 close of $4.95. Stockanalysis.com shows all four covering analysts at Hold as of October 2026.

Price setup

The shares closed at $4.95 on 9 October 2026, based on split- and dividend-adjusted daily closes. That is 45.0% below the 52-week high of $9.00, and the shares are down 25.0% over three months. The 14-day relative strength index (RSI) stands at 79.2, an overbought reading that reflects a sharp rebound in early October inside a longer decline.

UBS's $4.50 target sits about 9% below the last close. A move back under that level would erase the October rebound and put the shares at new lows for the three-month decline. The rebound came with no company release. The only company news in the period is the CFO appointment announced on 1 September 2026.

Crowding signals are mixed. The high RSI and a quarterly report about four weeks away point to short-term exposure to news. No dated insider sales or share issuance are on the record for the past month.

Catalysts, next 30 days

• 19 October 2026: Jennifer Ryu starts as CFO. The appointment itself is already known. Her first public comments on the balance sheet and the review would come with the quarterly report.
• ~5 November 2026, est.: Third-quarter 2026 results. Aggregators expect this date, and the company has not yet confirmed it. The report shows whether same-store sales are still falling at the second-quarter rate of 6.8%, and whether the cut 2026 guidance holds.

Elapsed catalysts

• Undated: Result of the strategic review that began 6 April 2026. A signed sale agreement would reprice the shares on the deal terms. An end to the review with no deal would remove the main support for the price. (passed 190d ago)

What would change the view

The case for lagging the index breaks if the board announces a definitive sale agreement at a premium to the market price. It also breaks if the third-quarter report shows same-store sales stabilizing near flat and the company keeps its $91.0–$97.0 million adjusted EBITDA forecast. Either outcome would turn the review from a hope into a floor under the shares.

The downside view is confirmed by a daily close below $4.50, UBS's target and below the October rebound. It is also confirmed by a third-quarter report with another cut to guidance, or by the review ending without a transaction.

What it trades with

Xponential Fitness sits in the consumer discretionary rotation group with VRA, SG, FOSL, LUXE, GME, ONON, MAT, FNKO, PVH and OLLI. The site's weekly tracking has had that group maturing for four straight weeks through 11 October 2026, after an accelerating reading on 13 September 2026. A cooling group sets a higher bar for any single name.

The stock's own drivers are mostly specific to the company: the sale process, the $522.4 million debt load and franchisee economics. Those should outweigh moves in the wider group. Interest rates and credit conditions matter more here than for most peers, because a leveraged sale depends on financing.